A retrospective analysis of the efficacy of immune checkpoint inhibitors (ICIs) to advanced non-small cell cancer (NSCLC) patients (pts) with central nerve system (CNS) metastasis.
Published on Jun 1, 2018in Journal of Clinical Oncology32.956
· DOI :10.1200/JCO.2018.36.15_SUPPL.E21042
e21042Background: In clinical practice of advanced NSCLC pts, a control of CNS metastasis is important issue. Several clinical trials of ICIs have demonstrated the survival benefit in advanced NSCL...